Prophylactic HQP1351 Therapy

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Prophylactic HQP1351 Therapy trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

WithdrawnPhase 2

NCT05604755

Prophylactic HQP1351 Therapy Post-transplants on Leukemia After Allo-HSCT

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) improves the long-term outcomes for Philadelphia chromosome-positive acute lymphoblastic leukemia…

China0Started 2022-01-01

Treatment: HQP1351( Olverembatinib dimesylate)